Hi, what are you looking for?
Jewish Business News
Search results for "nyse"
Business
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has completed first step to buy its rival Mylan N.V. (Nasdaq: MYL). The Israeli giant announced...
Business
Teva is now close to the 4.6% stake in Mylan that will give it standing in the Netherlands courts.
Business
Mylan has confirmed it will dual list on the TASE and Nasdaq if it acquires Perrigo
Business
Insight will buy a majority stake in the Tel Aviv based IT security firm at a company value of $100 million, according to reports.
Business
Abbott Laboratories (NYSE: ABT), said it would back the generic pharmaceutical company Mylan’s (MYL) $34 billion bid acquisition of Perrigo Co Plc (PRGO.N). Abbott...
Business
Launches global program from new office focused on mobile innovation and collaboration.
Business
A Credit Suisse study finds that most hostile bids fail, especially if antitrust concerns are involved.
World News
Co-Founder and Chairman Jack Dorsey to Become Interim CEO While Board Conducts Search Company Reaffirms Second Quarter 2015 Outlook
Business
Teva Chairman Yitzhak Peterburgand and Teva’s CEO Erez Vigodman, are pushing Mylan to take Teva’s $40 billion take-over bid offer seriously.
Business
Opko Health Inc. (NYSE: OPK; TASE: OPK), has agreed to buy Bio-Reference Laboratories Inc.(Nasdaq: BRLI) in a deal valued at about $1.5 billion. Opko said...